These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2299257)

  • 1. The bisphosphonate 2-PEBP inhibits cyclosporin A induced high-turnover osteopenia in the rat.
    Movsowitz C; Epstein S; Fallon M; Ismail F; Thomas S
    J Lab Clin Med; 1990 Jan; 115(1):62-8. PubMed ID: 2299257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of cyclosporin A on bone mineral metabolism in experimental diabetes mellitus in the rat.
    Epstein S; Takizawa M; Stein B; Katz IA; Joffe II; Romero DF; Liang XG; Li M; Ke HZ; Jee WS
    J Bone Miner Res; 1994 Apr; 9(4):557-66. PubMed ID: 8030444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined treatment with cyclosporin A and cortisone acetate minimizes the adverse bone effects of either agent alone.
    Movsowitz C; Schlosberg M; Epstein S; Ismail F; Fallon M; Thomas S
    J Orthop Res; 1990 Sep; 8(5):635-41. PubMed ID: 2388102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Raloxifene analog (LY117018 HCL) ameliorates cyclosporin A-induced osteopenia in oophorectomized rats.
    Bowman AR; Sass DA; Marshall I; Ma YF; Liang H; Jee WS; Epstein S
    J Bone Miner Res; 1996 Aug; 11(8):1191-8. PubMed ID: 8854256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclosporin A in the oophorectomized rat: unexpected severe bone resorption.
    Movsowitz C; Epstein S; Ismail F; Fallon M; Thomas S
    J Bone Miner Res; 1989 Jun; 4(3):393-8. PubMed ID: 2788358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of age on cyclosporin A-induced alterations in bone mineral metabolism in the rat in vivo.
    Katz I; Li M; Joffe I; Stein B; Jacobs T; Liang XG; Ke HZ; Jee W; Epstein S
    J Bone Miner Res; 1994 Jan; 9(1):59-67. PubMed ID: 8154310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of testosterone in cyclosporine-induced osteopenia.
    Bowman AR; Sass DA; Dissanayake IR; Ma YF; Liang H; Yuan Z; Jee WS; Epstein S
    J Bone Miner Res; 1997 Apr; 12(4):607-15. PubMed ID: 9101372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostaglandin E2 alleviates cyclosporin A-induced bone loss in the rat.
    Katz IA; Jee WS; Joffe II; Stein B; Takizawa M; Jacobs TW; Setterberg R; Lin BY; Tang LY; Ke HZ
    J Bone Miner Res; 1992 Oct; 7(10):1191-200. PubMed ID: 1456087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Azathioprine alone is bone sparing and does not alter cyclosporin A-induced osteopenia in the rat.
    Bryer HP; Isserow JA; Armstrong EC; Mann GN; Rucinski B; Buchinsky FJ; Romero DF; Epstein S
    J Bone Miner Res; 1995 Jan; 10(1):132-8. PubMed ID: 7747620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 17 beta-estradiol prevents osteopenia in the oophorectomized rat treated with cyclosporin-A.
    Joffe I; Katz I; Jacobs T; Stein B; Takizawa M; Liu C; Berlin J; Epstein S
    Endocrinology; 1992 Mar; 130(3):1578-86. PubMed ID: 1537307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon-gamma causes loss of bone volume in vivo and fails to ameliorate cyclosporin A-induced osteopenia.
    Mann GN; Jacobs TW; Buchinsky FJ; Armstrong EC; Li M; Ke HZ; Ma YF; Jee WS; Epstein S
    Endocrinology; 1994 Sep; 135(3):1077-83. PubMed ID: 8070349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the interaction of parathyroid hormone and cyclosporine a on bone mineral metabolism in the rat.
    Epstein S; Dissanayake IR; Goodman GR; Bowman AR; Zhou H; Ma Y; Jee WS
    Calcif Tissue Int; 2001 Apr; 68(4):240-7. PubMed ID: 11353952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclosporin-A in vivo produces severe osteopenia in the rat: effect of dose and duration of administration.
    Movsowitz C; Epstein S; Fallon M; Ismail F; Thomas S
    Endocrinology; 1988 Nov; 123(5):2571-7. PubMed ID: 3262506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperostosis induced by the bisphosphonate (2-PEBP) in the oophorectomized rat.
    Movsowitz C; Epstein S; Fallon M; Ismail F; Thomas S
    Calcif Tissue Int; 1990 Mar; 46(3):195-9. PubMed ID: 2106379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long term administration of prostaglandin inhibitors in vivo fail to influence cartilage and bone mineral metabolism in the rat.
    Boiskin I; Epstein S; Ismail F; Fallon MD; Levy W
    Bone Miner; 1988 Apr; 4(1):27-36. PubMed ID: 3263891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone mineral metabolism in T lymphocyte-deficient and -replete strains of rat.
    Buchinsky FJ; Ma Y; Mann GN; Rucinski B; Bryer HP; Paynton BV; Jee WS; Hendy GN; Epstein S
    J Bone Miner Res; 1995 Oct; 10(10):1556-65. PubMed ID: 8686513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of cyclosporin A administration and its withdrawal on bone mineral metabolism in the rat.
    Schlosberg M; Movsowitz C; Epstein S; Ismail F; Fallon MD; Thomas S
    Endocrinology; 1989 May; 124(5):2179-84. PubMed ID: 2785025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone mineral metabolism in experimental diabetes mellitus: osteocalcin as a measure of bone remodeling.
    Glajchen N; Epstein S; Ismail F; Thomas S; Fallon M; Chakrabarti S
    Endocrinology; 1988 Jul; 123(1):290-5. PubMed ID: 3133194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1,25 Dihydroxyvitamin D3 modifies cyclosporine-induced bone loss.
    Epstein S; Schlosberg M; Fallon M; Thomas S; Movsowitz C; Ismail F
    Calcif Tissue Int; 1990 Sep; 47(3):152-7. PubMed ID: 2224590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alendronate prevents cyclosporin A-induced osteopenia in the rat.
    Sass DA; Bowman AR; Yuan Z; Ma Y; Jee WS; Epstein S
    Bone; 1997 Jul; 21(1):65-70. PubMed ID: 9213009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.